enow.com Web Search

  1. Ads

    related to: pulmonary hypertension treatment medications

Search results

  1. Results from the WOW.Com Content Network
  2. Pulmonary hypertension - Wikipedia

    en.wikipedia.org/wiki/Pulmonary_hypertension

    Treatment of pulmonary hypertension is determined by whether the PH is arterial, venous, hypoxic, thromboembolic, or miscellaneous. If it is caused by left heart disease, the treatment is to optimize left ventricular function by the use of medication or to repair/replace the mitral valve or aortic valve. [68]

  3. Pulmonary arterial hypertension - Wikipedia

    en.wikipedia.org/.../Pulmonary_arterial_hypertension

    A pulmonary artery wedge pressure being less than 15 mmHg (also measured by right heart catheterization) excludes post-capillary bed (in the veins distal to the capillary bed) pulmonary hypertension. Pulmonary arterial hypertension is a subgroup of pulmonary hypertension and is categorized as World Health Organization as group 1. [3]

  4. Selexipag - Wikipedia

    en.wikipedia.org/wiki/Selexipag

    Selexipag, sold under the brand name Uptravi, is a medication developed by Actelion for the treatment of pulmonary arterial hypertension (PAH). [3] [4] Selexipag and its active metabolite, ACT-333679 (or MRE-269, the free carboxylic acid), are agonists of the prostacyclin receptor, which leads to vasodilation in the pulmonary circulation. [5]

  5. Soluble guanylate cyclase stimulator - Wikipedia

    en.wikipedia.org/wiki/Soluble_guanylate_cyclase...

    Soluble guanylate cyclase (sGC) stimulators are a class of drugs developed to treat heart failure, pulmonary hypertension, and other diseases. The first-in-class medication was riociguat, approved in 2013 for pulmonary hypertension. [1] [2] They have also been investigated for hypertension, systemic sclerosis, and sickle cell disease. [3] [1]

  6. Ambrisentan - Wikipedia

    en.wikipedia.org/wiki/Ambrisentan

    Ambrisentan, sold under the brand name Letairis among others, is a drug used for the treatment of pulmonary hypertension. [3] [5] It is an endothelin receptor antagonist. [3] The peptide endothelin constricts muscles in blood vessels, increasing blood pressure.

  7. Endothelin receptor antagonist - Wikipedia

    en.wikipedia.org/wiki/Endothelin_receptor_antagonist

    Macitentan, ambrisentan and bosentan are mainly used for the treatment of pulmonary arterial hypertension, while atrasentan is an experimental anti-cancer drug.

  1. Ads

    related to: pulmonary hypertension treatment medications